✦ LIBER ✦

Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial

✍ Scribed by Eva Ellebaek, Lotte Engell-Noerregaard, Trine Zeeberg Iversen, Thomas Moerch Froesig, Shamaila Munir, Sine Reker Hadrup, Mads Hald Andersen, Inge Marie Svane

Book ID: 118001970
Publisher: Springer-Verlag
Year: 2012
Tongue: English
Weight: 552 KB
Volume: 61
Category: Article
ISSN: 0340-7004
DOI: 10.1007/s00262-012-1242-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I/II trial of a dendritic cell vac

Phase I/II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanoma

✍ Steele, J C; Rao, A; Marsden, J R; Armstrong, C J; Berhane, S; Billingham, L J; 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 661 KB

Vaccination with autologous dendritic ce

Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial

✍ Trepiakas, Redas; Berntsen, Annika; Hadrup, Sine Reker; Bjørn, Jon; Geertsen, Po 📂 Article 📅 2010 🏛 Informa plc 🌐 English ⚖ 317 KB

Phase II Trial of Dendritic Cells Loaded

Phase II Trial of Dendritic Cells Loaded with Antigens from Self-Renewing, Proliferating Autologous Tumor Cells as Patient-Specific Antitumor Vaccines in Patients with Metastatic Melanoma: Final Report

✍ Dillman, Robert O.; Selvan, Senthamil R.; Schiltz, Patric M.; McClay, Edward F.; 📂 Article 📅 2009 🏛 Mary Ann Liebert 🌐 English ⚖ 216 KB

Clinical and immunomodulatory effects of

Clinical and immunomodulatory effects of bevacizumab and low-dose interleukin-2 in patients with metastatic renal cell carcinoma: results from a phase II trial

✍ Jorge A. Garcia; Tarek Mekhail; Paul Elson; Pierre Triozzi; Cheryl Nemec; Robert 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB

Patient-Specific Vaccines Derived from A

Patient-Specific Vaccines Derived from Autologous Tumor Cell Lines as Active Specific Immunotherapy: Results of Exploratory Phase I/II Trials in Patients with Metastatic Melanoma

✍ Dillman, Robert O.; DePriest, Carol; DeLeon, Cristina; Barth, Neil M.; Schwartzb 📂 Article 📅 2007 🏛 Mary Ann Liebert 🌐 English ⚖ 319 KB

Phase II trial of recombinant human inte

Phase II trial of recombinant human interleukin-2 and interferon-alpha-2a: Implications for the treatment of patients with metastatic melanoma

✍ Omar Eton; Moshe Talpaz; Kyoo H. Lee; Jeanne M. Rothberg; Joanna M. Brell; Rober 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 664 KB